Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Anesiva files Zingo sNDA for expanded pain indication
The sNDA submission is based on results of a multi-center, randomized, double-blind study in 699 adult patients, which demonstrated less procedural pain associated with blood draws or IV
The sNDA submission is based on results of a multi-center, randomized, double-blind study in 699 adult patients, which demonstrated less procedural pain associated with blood draws or IV
The new facility will primarily produce infant formula milk powder and other nutritional products. The new facility will become part of Wyeth’s global nutritional manufacturing and supply network
The market launch of Levulan PDT in Brazil is expected to follow shortly. Stiefel previously received regulatory approval for Levulan Kerastick from ANVISA (Agencia Nacional de Vigilancia Sanitaria)
NeuroAid10 is derived from NeuroAid and is a combination of ten all-natural ingredients. It is marketed in the US as an herbal dietary supplement with the indication to
Protea provides a number of free amenities as part of its gelSTAT service, including gel sample transport kits, destaining reagents, and prepaid sample shipment to the company. Both
Analysis of the compiled data from a total of 18 patients showed an overall statistically significant increase of the mean hematocrit values at weeks four, six and eight,
In a number of human melanoma model experiments, using SCID mice and the A375 human melanoma cell line, the company demonstrated that vitiligo-derived IgG preparations can prevent, in
Buckman is currently CEO and a director of Devax, a development-stage cardiovascular device company. Mr Buckman replaces Dan Galles, who has been acting board chairman since late 2006.
The P4 Pathways Program is intended to help patients, physicians, and payors. Physicians who elect to participate will be rewarded for delivering the right patient care at the
The product will be marketed by Perrigo under store brand labels and is comparable to McNeil Consumer Healthcare’s recently launched Zyrtec-D extended-release tablets, indicated for 12 hour relief